RELATIONS BETWEEN OXIDATIVE STRESS, HEPATOCYTE GROWTH FACTOR, AND LIVER DISEASE IN HEMODIALYSIS PATIENTS
- 1 January 2002
- journal article
- Published by Taylor & Francis in Renal Failure
- Vol. 24 (6) , 825-837
- https://doi.org/10.1081/jdi-120015684
Abstract
Background: Hepatocyte growth factor (HGF) and copper/zinc superoxide dismutase (Cu/Zn SOD) protect against tissue injury, including that due to oxidative stress (SOX). We studied whether they could be associated with each other, SOX markers, prevalence of viral hepatitis, and cardiovascular disease (CVD) and their laboratory surrogates in maintenance hemodialysis (HD) patients. Methods: In 24 patients, pre-dialysis serum HGF, plasma Cu/Zn SOD, total lipid peroxides, and serum autoantibodies against oxidized LDL were measured by ELISAs. Viral hepatitis B and C markers were determined by third generation microparticle ELISAs, and CVD was identified on a clinical basis. Results: In HD patients, circulating HGF, Cu/Zn SOD, and the other SOX markers were higher than in healthy controls, and HGF directly correlated with Cu/Zn SOD levels (P = 0.0006). Both HGF (P = 0.021) and Cu/Zn SOD (P = 0.017) were positively associated with prevalence of viral hepatitis and serum alanine aminotransferase activity (P = 0.021 and P = 0.040, respectively). Presence of CVD directly correlated with HGF (P = 0.001) but not with Cu/Zn SOD levels (P = 0.087). Circulating HGF positively related to serum C-reactive protein (P = 0.043). In patients without viral hepatitis and CVD, both HGF and Cu/Zn SOD were lower than in those with, and higher than in healthy controls. CVD (P = 0.003) and viral hepatitis (P = 0.024) were independent predictors of increased HGF, while positive viral hepatitis marker predicted increased Cu/Zn SOD levels (P = 0.019) in HD patients. There were no associations between HGF and the SOX markers in controls. Conclusions: In maintenance HD patients, circulating Cu/Zn SOD and HGF levels are increased, likely as a part of the reparatory reaction against liver damage. Viral hepatitis status and liver function should be considered in further studies of Cu/Zn SOD in these subjects.Keywords
This publication has 29 references indexed in Scilit:
- Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patientsNephrology Dialysis Transplantation, 2002
- Detoxification of Reactive Oxygen Species by A Nonpeptidyl Mimic of Superoxide Dismutase Cures Acetaminophen–Induced Acute Liver Failure in the MouseHepatology, 2001
- Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatmentNephrology Dialysis Transplantation, 2001
- Hepatocyte growth factor in renal failure: Promise and realityKidney International, 2000
- Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factorKidney International, 1999
- A Nonpeptidyl Mimic of Superoxide Dismutase with Therapeutic Activity in RatsScience, 1999
- Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?Nephrology Dialysis Transplantation, 1998
- Vascular expression of extracellular superoxide dismutase in atherosclerosis.Journal of Clinical Investigation, 1998
- Superoxide Dismutase and Catalase Activities in Patients Undergoing Hemodialysis and Continuous Ambulatory Peritoneal DialysisRenal Failure, 1996
- Antioxidant Enzymes Activity in Polymorphonuclear Leukocytes in Chronic Renal FailureNephron, 1995